<?xml version="1.0" encoding="UTF-8"?><xml><records><record><source-app name="Biblio" version="7.x">Drupal-Biblio</source-app><ref-type>17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Terpos, E.</style></author><author><style face="normal" font="default" size="100%">Anagnostopoulos, A.</style></author><author><style face="normal" font="default" size="100%">Kastritis, E.</style></author><author><style face="normal" font="default" size="100%">Bamias, A.</style></author><author><style face="normal" font="default" size="100%">Tsionos, K.</style></author><author><style face="normal" font="default" size="100%">Dimopoulos, M.-A.</style></author></authors></contributors><titles><title><style face="normal" font="default" size="100%">Abnormal bone remodelling and increased levels of macrophage inflammatory protein-1 alpha (MIP-1α) in Waldenström macroglobulinaemia</style></title><secondary-title><style face="normal" font="default" size="100%">British Journal of Haematology</style></secondary-title></titles><keywords><keyword><style  face="normal" font="default" size="100%">bone markers</style></keyword><keyword><style  face="normal" font="default" size="100%">Macrophage inflammatory protein-1 alpha</style></keyword><keyword><style  face="normal" font="default" size="100%">Osteoprotegerin</style></keyword><keyword><style  face="normal" font="default" size="100%">Receptor activator of nuclear factor-κB ligand</style></keyword><keyword><style  face="normal" font="default" size="100%">Waldenström macroglobulinaemia</style></keyword></keywords><dates><year><style  face="normal" font="default" size="100%">2006</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2006</style></date></pub-dates></dates><urls><web-urls><url><style face="normal" font="default" size="100%">https://www.scopus.com/inward/record.uri?eid=2-s2.0-33645450317&amp;doi=10.1111%2fj.1365-2141.2006.06017.x&amp;partnerID=40&amp;md5=c0988234eca47fc1ae936dcb393e48d9</style></url></web-urls></urls><volume><style face="normal" font="default" size="100%">133</style></volume><pages><style face="normal" font="default" size="100%">301 - 304</style></pages><language><style face="normal" font="default" size="100%">eng</style></language><abstract><style face="normal" font="default" size="100%">Serum levels of macrophage inflammatory protein-1 alpha (MIP-1α) and bone remodelling markers were evaluated in 38 patients with Waldenström macroglobulinaemia (WM) and correlated with clinical and laboratory variables. MIP-1α was elevated in WM; untreated patients had higher MIP-1α levels than patients in remission or with active disease after treatment. MIP-1α correlated with increased bone resorption, β2- microglobulin and splenomegaly. Receptor activator of nuclear factor-κB ligand serum levels were elevated in WM patients; the subsequent increased bone resorption was balanced by a comparable elevation of osteoprotegerin production and bone formation. These findings may explain the absence of lytic lesions in WM patients and suggest a potential role of MIP-1α in WM. © 2006 Blackwell Publishing Ltd.</style></abstract><issue><style face="normal" font="default" size="100%">3</style></issue><notes><style face="normal" font="default" size="100%">Cited By :18Export Date: 21 February 2017</style></notes></record></records></xml>